Risk of Severe COVID-19 in Non-Adherent OSA Patients
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F22%3A73614244" target="_blank" >RIV/61989592:15110/22:73614244 - isvavai.cz</a>
Alternative codes found
RIV/00216224:14110/22:00128092 RIV/65269705:_____/22:00076438 RIV/00098892:_____/22:10157298
Result on the web
<a href="https://www.dovepress.com/risk-of-severe-covid-19-in-non-adherent-osa-patients-peer-reviewed-fulltext-article-PPA" target="_blank" >https://www.dovepress.com/risk-of-severe-covid-19-in-non-adherent-osa-patients-peer-reviewed-fulltext-article-PPA</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.2147/PPA.S387657" target="_blank" >10.2147/PPA.S387657</a>
Alternative languages
Result language
angličtina
Original language name
Risk of Severe COVID-19 in Non-Adherent OSA Patients
Original language description
Background: Patients with obstructive sleep apnoea (OSA) are at increased risk of severe course of COVID-19. Vaccination remains to be the most effective prevention of complicated courses of infection. The best contemporary conservative treatment of OSA is continuous positive airway pressure (CPAP) therapy.Purpose: To compare vaccination acceptance and outcomes of COVID-19 infection between OSA patients adhering to the CPAP therapy and those who rejected CPAP and surgical therapy.Patients and Methods: Subjects were divided into two groups: group A (N = 167) were individuals with sufficient CPAP adherence (more than 4 hours per night on average) over the last 10 years. Group B (N = 106) were individuals who did not use the CPAP therapy at all and had no indications to surgical therapy.Results: Three patients in group B died, and one had a severe course of COVID-19. None of the patients in group A died or experienced a severe course of COVID-19. Group A had a significantly higher proportion of males (77.8% compared to 66% in group B) and all parameters of OSA severity. The vaccination status was similar among both groups, with a complete triple dose vaccination rate of 69.5% and 67.9% in groups A and B, respectively.Conclusion: The results show that the patients with OSA adherent to CPAP therapy were less likely to experience a severe course of COVID-19 or death than the OSA patients non-compliant with therapy, despite the former group having more severe OSA. This result underlines the importance of adherence to CPAP therapy in OSA.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30203 - Respiratory systems
Result continuities
Project
<a href="/en/project/NU22-A-105" target="_blank" >NU22-A-105: Predicitve biomarkers of therapeutic response on COVID-19 therapy</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2022
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Patient Preference and Adherence
ISSN
1177-889X
e-ISSN
—
Volume of the periodical
16
Issue of the periodical within the volume
2022
Country of publishing house
NZ - NEW ZEALAND
Number of pages
11
Pages from-to
3069-3079
UT code for WoS article
000884754000001
EID of the result in the Scopus database
2-s2.0-85141348758